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Abstract 
Background: Malnutrition is associated with higher risk of mortality in maintenance hemodialysis 
(MHD) patients. The geriatric nutritional risk index (GNRI) has been developed as a tool to assess 
the nutritional risk. Objectives: The purpose of the present study was to examine the significance 
of the GNRI as a mortality predictor in MHD patients. Methods: We retrospectively examined the 
GNRI of 259 MHD patients aged 59.2 ± 12.8 years, and followed up for 36 months. The patients 
were divided into two groups according to GNRI values of 91.0. Predictors for all-cause mortality 
were examined using Kaplan-Meier and Cox proportional-hazards analyses. Results: During the 
follow-up period of 36 months, a total of 76 patients died. Kaplan-Meier survival analysis showed 
that the subjects with a GNRI < 91 (n = 29) had a lower survival rate than those with a GNRI > 91 (n 
= 230) (Log-rank test, p < 0.0001). Multivariate Cox proportional-hazards analysis demonstrated 
that the GNRI was a significant predictor of adjusted all-cause mortality (hazard ratio 0.927; con-
fidence interval 0.870 - 0.984, p = 0.013). Conclusion: The results of the present study demon-
strate that the GNRI is a strong predictor of all-cause mortality in MHD patients. 
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1. Introduction 
Protein-energy wasting (PEW) is an important issue in hemodialysis (HD) patients, with a reported prevalence 
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ranging from about 20% to 78% [1]. Nutritional risk factor is one of the strong predictors of mortality in HD pa-
tients [2] [3]. Thus, evaluation of nutritional status is essential clinical procedure for managing these patients. 
Multiple mechanisms have been reported to explain the link between PEW and mortality in HD patients, in-
cluding derangements in muscle, adipose tissue, gastrointestinal, hematopoietic and immune systems, abnormal 
activation of the inflammatory process [4]. A clinical assessment of nutritional status is mandatory in HD pa-
tients, but there is no single gold-standard method, easily performed in a reproducible manner and not affected 
by other confounding conditions. Therefore, it is necessary to screen patients for the presence of PEW with a 
variety of measures and to perform this investigation on a regular clinical practice [5]. 
The geriatric nutritional risk index (GNRI) is a very simple method based on body weight, height and serum 
albumin levels to assess nutritional status in various pathological conditions. Previous studies have investigated 
the reliability of GNRI in assessing malnutrition [6] and in predicting all-cause mortality in chronic HD patients 
[7] [8]. All the reported studies in uremic patients were performed, however, in Asian cohorts and data from 
European, or Caucasian, populations are lacking. 
The purpose of the present study was to evaluate the GNRI as a nutritional tool for predicting mortality in a 
Japanese MHD population. 
2. Methods 
2.1. Study Subjects and Procedures 
This was a retrospective cohort study conducted at a single center in Japan. The subjects were recruited from 
among patients who had been routinely treated through an arteriovenous fistula in the dialysis unit of the Shin-
juku Ishikawa Clinic for at least 6 months. The Institutional Review Board of the Shinjuku Ishikawa Clinic ap-
proved all study protocols, and they were performed in accordance with the Declaration of Helsinki guidelines 
regarding ethical principles for medical research involving human subjects. Informed consent was obtained from 
all of the subjects.  
HD patients with malignancy, active inflammation, liver cirrhosis, gastrointestinal bleeding, or severe illness 
were excluded from participation. The patients who were enrolled as subjects (n = 259) underwent stable regular 
HD with a bicarbonate dialysate. Their underlying diseases were chronic glomerulonephritis (n = 98), diabetic 
nephropathy (n = 76), hypertensive nephrosclerosis (n = 52), polycystic kidney disease (n = 18), and chronic 
pyeonephritis (n = 9), or unknown origin (n = 6). 
All patients were on thrice-weekly HD and no further selection was performed in patients. Blood pressure (BP) 
was measured with a mercury sphygmomanometer with the patient in the supine position after resting for 10 to 
15 minutes, and mean values for the 1-month period preceding enrollment were used in the statistical analysis. 
Dry weight was targeted to achieve a normotensive edema-free state. Previous cardiovascular disease and 
smoking status were collected from medical records. Diabetes was defined as a history or presence of diabetes 
and/or a fasting plasma glucose concentration > 126 mg/dl or HbA1c concentration > 6.5% or prescription of 
glucose-lowering agents. 
2.2. Laboratory and Nutritional Parameters 
Blood sampling was performed before the mid-week dialysis session day after an overnight fast. Serum urea ni-
trogen, creatinine, calcium, phosphorous, albumin, total cholesterol, high-density lipoprotein (HDL)-cholesterol 
and C-reactive protein (CRP) levels and the hemoglobin concentration were measured with an autoanalyzer 
(Hitachi Co., Tokyo, Japan) by standard laboratory methods. Total calcium was corrected by the patient’s albu-
min level. Intact parathyroid hormone (iPTH) was measured by an immunoradiometric assay (Nichol’s Institute, 
San Juan Capistrano, CA, USA). The body mass index (BMI) was expressed in kg/m2. Urea kinetics were as-
sessed by measuring a blood-based dialysis parameter, Kt/V [9], and the mean value of the 3 measurements 
during each of the 3 months before the start of the study was used in the analysis. The normalized protein cata-
bolism rate (nPCR) was used as an indirect indicator of protein intake and was obtained using the following 
formula as previously described [10]. 
The GNRI was calculated by modifying the Nutritional risk index for elderly patients, as reported by Yamada 
et al. [6] as follows: GNRI = [14.89 × albumin (g/dl)] + [41.7 × (body weight/ideal body weight)]. As body 
weight we considered the value at the end of the dialysis session, and it was used also for BMI calculation. Body 
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weight/ideal body weight was set to 1 when the patient’s body weight exceeded the ideal body weight [6]. The 
ideal body weight in the present study was calculated using height and a BMI of 22, which is reportedly asso-
ciated with the lowest morbidity rate in the Asian population [11]. 
2.3. Study Outcome 
Data for endpoints were obtained from hospital charts. Primary endpoint of the study was all-cause mortality 
during the follow-up period from January 1, 2011, to December 31, 2014. The vital status of the subjects was 
assessed by searching the electronic dialysis records. Patients were censored if they were alive on December 31, 
2014. 
2.4. Statistical Analysis 
Normally distributed, unpaired continuous values were expressed as means ± SD and compared by performing 
an analysis of variance. Nonparametric values were expressed as median values and compared by performing 
the Kruskal-Wallis test. Categorical values were expressed as percentages and compared by performing the 
Fisher’s exact test. Logistic regression analysis was used in a model to determine how independent variables 
predicted the GNRI value. We considered some variables that possess P-value < 0.10 in univariate logistic re-
gression analyses, gender, dialysis vintage, and presence of diabetes as independent variables for multivariate 
logistic regression analyses. The area under the receiver operating curve (ROC) analysis was performed to cal-
culate the cut-off values of GNRI. 
The survival analysis was based on the Kaplan-Meier curve with subjects censored for death. A log-rank test 
was used to compare the survival rates of two groups. A multivariate Cox proportional hazards model with ad-
justment for multivariate factors was used to evaluate mortality risk. Results were expressed as a hazard ratio 
(HR) with 95% confidence intervals (CIs). A P-value < 0.05 was considered to be statistically significant. All 
statistical analyses were performed by using the SAS version 9.2 software program (SAS Institute Inc., Cary, 
NC, USA) for Windows personal computers. 
3. Results 
The baseline characteristics of the study population are shown in Table 1. The mean age of the 259 subjects was 
59.2 ± 12.8 years, and the mean dialysis vintage was 131.3.2 ± 92.0 years months. The prevalence of diabetes 
68.0% in all subjects. The study population included 70 women and 189 men. To determine a possible cut-off 
value of GNRI for survival, the sensitivity and specificity were examined by ROC analysis. A GNRI value of 91 
was shown to indicate the highest value for sensitivity and specificity (Figure 1). The AUC for GNRI from 
ROC analysis was 0.673 (95% CI, 0.545 - 0.781) and the positive likelihood for GNRI was 4.719. 
The clinical characteristics of the 259 subjects according to GNRI are shown in Table 2. The mean GNRI 
value of the subjects with a GNRI < 91 was 87.6 ± 3.3, and that of the subjects with a GNRI > 91 was 101.8 ± 
7.4. Subjects with a GNRI < 91 exhibited significantly older age, lower body weight and BMI, lower serum al-
bumin and creatinine compared with those with a GNRI > 91. As shown in Figure 2, there was a significant 
correlation between age and GNRI (r = −0.3515, P < 0.0001). 
During the follow-up period of 36 months, a total of 26 patients died. The Kaplan-Meier analysis revealed 
that subjects with a GNRI < 91 (n = 29) had a significant lower survival rate compared with that of those with a 
GNRI > 91 (n = 230) (P < 0.0001, Figure 3). Univariate Cox proportional hazards analysis for mortality showed 
that age (HR 1.079, 95% CI 1.042 - 1.119, P < 0.0001), serum levels of albumin (HR 0.185, 95% CI 0.065 - 
0.580, P = 0.0043), creatinine (HR 0.720, 95% CI 0.612 - 0.846, P < 0.0001) and calcium (HR 1.979, 95% CI 
1.091 - 3.577, P = 0.0245) were significant predictor of mortality (Table 3). Multivariate Cox proportional ha-
zards analysis demonstrated that GNRI was a significant predictor of mortality (HR 0.927, 95% CI 0.870 - 0.984, 
P = 0.0130) (Table 4). In addition, age (HR 1.063, 95% CI 1.023 - 1.107, P = 0.0016), Kt/V (HR 0.058, 95% CI 
0.005 - 0.682, P = 0.0233) and serum calcium levels (HR 1.819, 95% CI 1.090 - 3.004, P = 0.0226) were also 
significant predictors of mortality. 
4. Discussion 
We investigated the GNRI as a nutritional tool for predicting mortality in a Japanese MHD population. We used  
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Figure 1. Receiver operating curve analysis to examine a cut- 
off value of GNRI for all-cause mortality. 
 
Table 1. Baseline characteristics of the study population. 
Variable N = 259 
Age (years) 59.2 ± 12.8 
Men/women 189/70 
Dialysis vintage (months) 131.3 ± 92.0 
Diabetes (−/+) 176/83 
Body weight (kg) 60.2 ± 13.5 
Body mass index 22.3 ± 3.7 
Albumin (g/dl) 3.9 ± 0.3 
Blood urea nitrogen (mg/dl) 68.0 ± 14.9 
Creatinine (mg/dl) 11.9 ± 2.4 
C-reactive protein (mg/dl) 0.30 ± 0.44 
GNRI 100.2 ± 8.4 
Kt/V 1.45 ± 0.24 
Systolic blood pressure (mmHg) 152.1 ± 22.6 
Diastolic blood pressure (mmHg) 82.4 ± 14.6 
Normalized PCR 0.93 ± 0.17 
Hemoglobin (g/dl) 10.6 ± 0.9 
Ferritin (ng/ml) 72.7 ± 75.6 
Calcium (mg/dl) 9.0 ± 0.7 
Phosphorus (mg/dl) 5.4 ± 1.2 
Intact PTH (pg/ml) 76.2 ± 66.8 
Uric acid 7.5 ± 1.1 
Total cholesterol (mg/dl) 158.9 ± 31.8 
HDL-cholesterol (mg/dl) 47.3 ± 14.9 
Non-HDL-cholesterol (mg/dl) 111.6 ± 31.7 
GNRI, geriatric nutritional risk index; PCR, protein catabolic rate; PTH, 
parathyroid hormone. 
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Figure 2. Relationship between age and GNRI. 
 
Table 2. Clinical characteristics of 259 study subjects according to geriatric nutritional risk 
index (GNRI). 
 GNRI < 91 GNRI ≥ 91 P 
Age (years) 65.8 ± 13.4 58.4 ± 12.5 0.0029 
Men/women 16/13 173/57 0.0274 
Dialysis vintage (months) 147.0 ± 95.2 129.3 ± 91.6 0.3303 
Diabetes (−/+) 21/8 155/75 0.6762 
Body weight (kg) 46.9 ± 8.5 61.9 ± 13.0 <0.0001 
Body mass index 18.2 ± 1.8 22.9 ± 3.6 <0.0001 
Albumin (g/dl) 3.6 ± 0.3 3.9 ± 0.3 <.0001 
Blood urea nitrogen (mg/dl) 64.6 ± 15.3 68.5 ± 14.8 0.1843 
Creatinine (mg/dl) 9.8 ± 2.3 12.1 ± 2.3 <0.0001 
C-reactive protein (mg/dl) 0.32 ± 0.44 0.30 ± 0.45 0.8314 
GNRI 87.6 ± 3.3 101.8 ± 7.4 <0.0001 
Kt/V 1.6 ± 0.3 1.4 ± 0.2 0.0194 
Systolic blood pressure (mmHg) 147.0 ± 28.3 152.7 ± 21.7 0.2018 
Diastolic blood pressure (mmHg) 78.7 ± 14.7 82.9 ± 14.6 0.1497 
Normalized PCR 0.92 ± 0.18 0.93 ± 0.17 0.5988 
Hemoglobin (g/dl) 10.4 ± 1.2 10.6 ± 0.8 0.1935 
Ferritin (ng/ml) 95.1 ± 83.2 69.9 ± 74.3 0.0966 
Calcium (mg/dl) 8.9 ± 0.9 9.0 ± 0.6 0.5181 
Phosphorus (mg/dl) 5.1 ± 1.5 5.5 ± 1.2 0.1140 
Intact PTH (pg/ml) 86.9 ± 75.2 74.8 ± 65.7 0.3590 
Uric acid (mg/dl) 7.2 ± 1.0 7.5 ± 1.1 0.1583 
Total cholesterol (mg/dl) 157.2 ± 34.7 159.2 ± 31.5 0.7522 
HDL-cholesterol (mg/dl) 49.6 ± 17.1 47.1 ± 14.7 0.3849 
Non-HDL-cholesterol (mg/dl) 107.6 ± 34.5 112.1 ± 31.4 0.4680 
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Figure 3. Kaplan-Meier survival curves for all-cause mortality according to geriatric nutri-
tional risk index values. 
 
Table 3. Univariate Cox proportional hazards analysis of mortality. 
 HR 95%CI P 
Age (/years) 1.079 1.042 - 1.119 <0.0001 
Men (vs. women) 1.534 0.625 - 4.595 0.3697 
Dialysis vintage (/months) 1.003 0.999 - 1.006 0.1855 
Diabetes (vs. No) 1.187 0.506 - 2.603 0.6806 
Body weight (/kg) 0.978 0.945 - 1.008 0.1585 
Body mass index (/1) 0.922 0.814 - 1.031 0.1629 
Albumin (g/dl) 0.185 0.065 - 0.580 0.0043 
Blood urea nitrogen (/mg/dl) 0.984 0.958 - 1.010 0.2339 
Creatinine (/mg/dl) 0.720 0.612 - 0.846 <0.0001 
C-reactive protein (/mg/dl) 1.416 0.655 - 2.378 0.3246 
GNRI (/1) 0.928 0.880 - 0.977 0.0037 
Kt/V (/1) 0.225 0.040 - 1.227 0.0854 
Systolic blood pressure (/mmHg) 1.011 0.993 - 1.028 0.2326 
Diastolic blood pressure (/mmHg) 0.991 0.965 - 1.017 0.4789 
Normalized PCR (/1) 0.145 0.013 - 1.473 0.1035 
Hemoglobin (/g/dl) 1.126 0.728 - 1.814 0.6100 
Ferritin (/ng/ml) 1.003 0.999 - 1.006 0.1488 
Calcium (/mg/dl) 1.979 1.091 - 3.577 0.0245 
Phosphorus (/mg/dl) 0.765 0.539 - 1.063 0.1135 
Intact PTH (/pg/ml) 1.004 0.999 - 1.008 0.1307 
Uric acid (/mg/dl) 0.885 0.610 - 1.253 0.5009 
Total cholesterol (/mg/dl) 0.997 0.985 - 1.009 0.6601 
HDL-cholesterol (/mg/dl) 0.973 0.942 - 1.001 0.0571 
Non-HDL-cholesterol (/mg/dl) 1.002 0.990 - 1.014 0.6795 
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Table 4. Multivariate Cox proportional hazards analysis of mortality. 
 HR 95%CI P 
Age (/years) 1.063 1.023 - 1.107 0.0016 
Men (vs. women) 1.228 0.425 - 4.186 0.7175 
Dialysis vintage (/months) 1.003 0.998 - 1.007 0.2143 
Diabetes (vs. No) 1.181 0.479 - 2.774 0.7081 
GNRI (/1) 0.927 0.870 - 0.984 0.0130 
Kt/V (/1) 0.058 0.005 - 0.682 0.0233 
Calcium (/mg/dl) 1.819 1.090 - 3.004 0.0226 
 
a cut-off value of GNRI of 91 to identify subjects with the highest risk according to ROC analysis. Subjects with 
a GNRI < 91 had a significant lower survival rate compared with that of those with a GNRI > 91. The results of 
the present study clearly showed that the GNRI value represents a strong predictor for all-cause mortality in 
Japanese HD patients. 
Assessment of nutritional status is essential to prevent, diagnose and treat uremic malnutrition in uremic pa-
tients [5]. Biochemistry, anthropometry, body composition analysis, and interviews are variably used together 
with scores and indexes to obtain a comprehensive assessment of the nutritional status in uremic patients [5]. 
Many nutritional screening tools have been reported in the elderly, hospitalized patients, community patients, or 
patients with cancer or infections. Some of them may be safely and easily applied to MHD patients as well [12]. 
The Subjective Global Nutritional Assessment is a well validated clinical tool for screening malnutrition [2] and 
the malnutrition-inflammation score (MIS) is able to predict mortality and hospitalization in MHD patients [13]. 
However, both require subjective assessment and judgment by a skilled investigator. 
In the present study, GNRI was one of the parameters as a predictor of all-cause mortality. The GNRI consists 
of few objective components, including serum albumin and BMI and represents a simple nutritional screening 
tool [6]. The GNRI score has been shown able to predict increased healthcare costs and higher risk of hospitali-
zation in independent-living older adults; so it may be a low-cost tool that might be routinely used in popula-
tion-based settings [14]. 
Yamada et al. [6] suggested that the most accurate GNRI cut-off value to identify malnourished HD patients 
was < 91.2, based on the MIS. Kobayashi et al. [7] reported that HD patients with GNRI < 90 exhibited a poorer 
nutritional status in terms of a lower BMI, serum levels of albumin and creatinine compared with GNRI > 90. 
Park et al. [8] confirmed in Korean HD patients that GNRI may be a significant predictor of mortality. More re-
cently, Panichi et al. [15] have shown that values lower than 92 may represent a strong indicator of unfavorable 
outcome in Caucasian HD patients. 
Takahashi et al. have recently indicated that GNRI at initiation of HD therapy could predict cardiovascular 
mortality with incremental value of the predictability compared to serum albumin and body mass index in HD 
patients [16]. Although the lowest GNRI quartile (<92) is strongly associated with malnutrition signs and with 
increased risk of all-cause mortality, no predictive value emerged regarding non-fatal cardiovascular events in 
HD patients. This apparent discrepancy may be explained considering that malnourished patients have lower 
survival and so less chance to develop a cardiovascular event, but when a cardiovascular event does occur, a 
malnourished patient has less chance to recover and more chance to die. Our data also clearly confirmed the re-
liability of GNRI as a tool for the diagnosis of malnutrition in a longitudinal observation [17].  
Various mechanisms may explain the link between PEM and mortality in renal failure, including derange-
ments in muscle, adipose tissue, gastrointestinal, hematopoietic and immune systems, and abnormal activation 
of the inflammatory process [18], as well as co-morbidities. Low albumin, cholesterol, and BMI are indicators 
of PEM, but they may not be causally responsible for the negative outcome. The reduction in muscle mass, 
namely sarcopenia, observed in PEM may be due to uremic toxins or procatabolic conditions (metabolic, hor-
monal, or neuropathic derangements, including inactivity). 
There are some limitations in this study that should be considered. First, this study is based on a relatively 
small sample size of HD patients from a single center, limiting the ability of our findings to be generalized. 
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Second, this study used only a retrospective approach, without manipulation of confounding factors. We could 
not rule out a recalling bias. Randomized, controlled trials are needed to explore the role of GNRI value on 
mortality risk in chronic HD patients. Third, we did not show the prescription of renin-angiotensin system inhi-
bitors, statins, and vitamin D. These agents may affect the mortality risk of GNRI. Fourth, other confounding 
factors may be neglected because the GNRI was calculated from the formula including serum albumin and BMI. 
5. Conclusion 
The results of the present study clearly show that GNRI values are significantly associated with all-cause mor-
tality in Japanese HD patients. We conclude that the GNRI may be a very simple tool to use that may be consi-
dered as a reliable predictor for all-cause mortality risk in the HD population. 
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